AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9263186
Drug: Mineral group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mineral group: 20 mg zinc, 100 micrograms selenium
Trial: 9263186
Drug: Vitamin group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin group: 120 mg vitamin C, 6 mg beta‐carotene, 15 mg vitamin E
Trial: 9263186
Drug: Mineral and
RxNorm normalized name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15.2 g in 100 g TOPICAL STICK [Dove Men plus Care Elements Mineral and Sage Antiperspirant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mineral and vitamin group: Zn 20 mg, Se 100 micrograms, Vit C 120 mg, beta CA 6 mg, Vit E 15 mg
Trial: 21548978
Drug: Flexible nasendoscope
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible nasendoscope with gel cap
Trial: 21548978
Drug: Flexible nasendoscope
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible nasendoscope without gel cap (control)
Trial: 12584786
Drug: Rhubarb treatment
RxNorm normalized name: RHUBARB
DrugBank: Rhubarb (DB10651)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhubarb treatment
Trial: 16787193
Drug: Atorvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (40 mg/day) for 7 days
Trial: 12672280
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of Daily Living (ADL) assessment
Trial: 7742052
Drug: Prophylactic somatostatin
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic somatostatin (4.5 mg daily in continuous perfusion for 7 days postoperatively)
Trial: 31657637
Drug: 750-g ice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750-g ice bag applied for 10 to 60 minutes based on subcutaneous adipose thickness
Trial: 28178599
Drug: Dexpramipexole (50mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexpramipexole (50mg to 300mg daily)
Trial: 18071079
Drug: Quinapril, target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril, target dose 40 mg/d
Trial: 12672922
Drug: Sprinkles containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sprinkles containing 80 mg iron and 10 mg zinc (FeZn)
Trial: 12672922
Drug: Sprinkles containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sprinkles containing 80 mg iron (Fe)
Trial: 8729205
Drug: Clemastine fumarate
RxNorm normalized name: Clemastine Fumarate
DrugBank: Clemastine (DB00283)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clemastine fumarate (1.34 mg)
Trial: 26984569
Drug: 12-month physical
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month physical exercise program, 40 minutes twice weekly for 1 year
Trial: 22025490
Drug: Continuous wound
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous wound infusion with ropivacaine 2 mg/mL at 5 mL/h for 48 hours
Trial: 22025490
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 2 mg every 12 hours for 48 hours
Trial: 22025490
Drug: Continuous wound
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous wound infusion with ropivacaine
Trial: 20811292
Drug: CC+CT genotype
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC+CT genotype of rs2006765
Trial: 18642564
Drug: Cytotec (Misoprostol)
RxNorm normalized name: misoprostol Oral Tablet [Cytotec]
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cytotec (Misoprostol) oral application (50 microg every 4 hours, max 200 microg)
Trial: 18642564
Drug: Cytotec (Misoprostol)
RxNorm normalized name: misoprostol Oral Tablet [Cytotec]
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cytotec (Misoprostol) vaginal application (two doses of 50 microg every 6 hours)
Trial: 9598451
Drug: Triple combination
RxNorm normalized name: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple combination (1.07 mg/kg mefloquine, 2.14 mg/kg sulfadoxine, 0.11 mg/kg pyrimethamine)
Trial: 9598451
Drug: Sulfadoxine/pyrimethamine (2.14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine/pyrimethamine (2.14 mg/kg sulfadoxine, 0.11 mg/kg pyrimethamine)
Trial: 9598451
Drug: Mefloquine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine alone (1.07 mg/kg)
Trial: 3280128
Drug: Biperiden (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biperiden (5.0 mg)
Trial: 3280128
Drug: Clonazepam (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (1.0 mg)
Trial: 3280128
Drug: Lisuride (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisuride (0.05 mg)
Trial: 25829103
Drug: Psycho-education combined
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psycho-education combined with pharmacotherapy
Trial: 21138825
Drug: Exenatide, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide, 10 µg twice daily for 30 weeks
Trial: 18822845
Drug: Combination pharmacotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination pharmacotherapy with antihypertensive drugs
Trial: 16847290
Drug: Sibutramine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (10 mg, uptitrated to 15 mg if necessary)
Trial: 10320243
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (group MP)
Trial: 10320243
Drug: Intravenous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous placebo (group NS)
Trial: 1924643
Drug: Nicotine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (single dose)
Trial: 1924643
Drug: Scopolamine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine (single dose)
Trial: 27426024
Drug: Yoga training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga training (60-min classes weekly for six months)
Trial: 15969863
Drug: Pre-treatment erythropoietin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment erythropoietin levels
Trial: 12870985
Drug: Ferric sulphate
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric sodium citrate (DB13771)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferric sulphate (FS) 15.5% solution applied for 15 seconds
Trial: 2025573
Drug: Daunorubicin, cytosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daunorubicin, cytosine arabinoside and thioguanine combination
Trial: 30199128
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy (SP)
Trial: 26136435
Drug: Orofacial Myofunctional
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orofacial Myofunctional Therapy (OMT)
Trial: 22914255
Drug: Polyphenol-rich olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyphenol-rich olive oil (∼30 mg/day)
Trial: 18561116
Drug: Neuromonics Tinnitus
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromonics Tinnitus Treatment (customized neural stimulus)
Trial: 18561116
Drug: Neuromonics Tinnitus
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromonics Tinnitus Treatment
Trial: 15809910
Drug: ORS with
RxNorm normalized name: SODIUM FLUORIDE 2.43 mg in 1 g ORAL PASTE, DENTIFRICE [Dr Tichenors With Extra Whitening and Tartar Control]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORS with L-histidine (2.5 g/L)
Trial: 15809910
Drug: ORS without
RxNorm normalized name: Orserdu
DrugBank: Elacestrant (DB06374)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORS without L-histidine
Trial: 12398233
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (Ortho Tri-Cyclen: norgestimate and ethinylestradiol)
Trial: 10605165
Drug: Lamotrigine monotherapy
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine monotherapy (206.4 ± 44.4 mg/day)
Trial: 10605165
Drug: Lamotrigine combined
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine combined with carbamazepine (1208 ± 82.9 mg/day + 561.7 ± 76.8 mg/day)
Trial: 1659440
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg ml‐1 443C81
Trial: 1659440
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ml‐1 443C81
Trial: 7037414
Drug: Oxprenolol 40
RxNorm normalized name: oxprenolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol 40 mg b.d.
Trial: 30273200
Drug: Ultra-low-dose IT
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-low-dose IT naloxone (20 μg) and IT morphine (0.2 mg)
Trial: 30273200
Drug: IT morphine
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IT morphine (0.2 mg) alone
Trial: 31003657
Drug: Active video
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active video game intervention (twice a week for 45 minutes over eight weeks)
Trial: 25542616
Drug: Neutral shampoo
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral shampoo eyelid hygiene plus topical metronidazole gel 0.75% twice/day
Trial: 25542616
Drug: Neutral eyelid
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral eyelid hygiene with shampoo plus neomycin 3.5% and polymyxin 10% antibiotic ointment with 0.5% dexamethasone 3 times/day
Trial: 18288078
Drug: Midazolam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (2 mg p.o.)
Trial: 18288078
Drug: Digoxin (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (0.25 mg p.o.)
Trial: 12757769
Drug: Oral anticoagulants
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulants (OAC) with a target INR of 2.0-2.5 and aspirin 75 mg/day
Trial: 3613407
Drug: Heparin free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin free hemodialysis
Trial: 3613407
Drug: Systemic heparinization,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic heparinization, intermittent saline flushes, and constant saline infusions
Trial: 30368509
Drug: Daily treatment
RxNorm normalized name: BENZOYL PEROXIDE 2.5 g in 100 g TOPICAL GEL [Acne defense Daily Treatment Serum Merle Norman]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily treatment with S-1
Trial: 30368509
Drug: Alternate-day treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day treatment with S-1
Trial: 22918663
Drug: Full mouth
RxNorm normalized name: moth bean extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full mouth non‐surgical periodontal therapy followed by open flap surgery
Trial: 16114063
Drug: Clover phytoestrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clover phytoestrogens 240 mg daily for 2 weeks
Trial: 14526951
Drug: Urinary excretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary excretion rates measured in microg U g(‐1) creatinine for 1997 and 1999.
Trial: 10971313
Drug: Intravenous diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diltiazem (loading dosage and constant infusion)
Trial: 20012601
Drug: Oral lovastatin
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral lovastatin (20 mg)
Trial: 8617086
Drug: PGI2 (Prostacyclin)
RxNorm normalized name: PGI2
DrugBank: Epoprostenol (DB01240)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGI2 (Prostacyclin) at a dose of 2 to 12 ng/kg/min, IV, infused continuously for 48 h
Trial: 1548451
Drug: Caffeine 178
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine 178 mg
Trial: 1548451
Drug: Caffeine doses
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine doses (100 mg, 56 mg, 32 mg, 18 mg, 10 mg)
Trial: 2984846
Drug: 0.28 ml
RxNorm normalized name: ethanol 0.28 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.28 ml of Rh-positive red cells (challenge)
Trial: 23141144
Drug: Clobazam at
RxNorm normalized name: Clobazam
DrugBank: Clobazam (DB00349)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clobazam at dosages ≤2.0 mg/kg/day (≤80 mg/day)
Trial: 20979934
Drug: Probenecid (PRB)
RxNorm normalized name: Probenecid
DrugBank: Probenecid (DB01032)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Probenecid (PRB) co-administered with Mizoribine (MZR)
Trial: 12798283
Drug: Glucose 100
RxNorm normalized name: glucose 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose 100 mg/kg
Trial: 12798283
Drug: Glucose 500
RxNorm normalized name: glucose 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose 500 mg/kg
Trial: 12798283
Drug: Glucose 50
RxNorm normalized name: glucose 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose 50 g
Trial: 12798283
Drug: Placebo (23.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (23.7 mg saccharin)
Trial: 8961362
Drug: 44 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 44 Gy in 16 daily fractions of radiation therapy (RT)
Trial: 8144848
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment alone
Trial: 8144848
Drug: GH +
RxNorm normalized name: Delsym Cough + Cold Daytime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH + LHRHa treatment
Trial: 3529772
Drug: 5000 IU
RxNorm normalized name: D 5000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 IU of heparin + 0.5 mg dihydroergotamine (HDHE) s.c. every 12 hours
Trial: 3529772
Drug: 5000 IU
RxNorm normalized name: D 5000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 IU of heparin (LDH) s.c. every 8 hours
Trial: 19167589
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg QD
Trial: 15938887
Drug: Before tooth
RxNorm normalized name: Sus scrofa tooth preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Before tooth preparation and 3 months after fixed prosthesis insertion
Trial: 15320851
Drug: Combination ARB/ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination ARB/ACE inhibitor therapy
Trial: 15320851
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor therapy alone
Trial: 8029088
Drug: Buserelin, 1800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin, 1800 micrograms/day as nasal spray
Trial: 8029088
Drug: Triptorelin Depot,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin Depot, 3.75 mg/every 4 weeks i.m.
Trial: 2567345
Drug: SKF 39393
RxNorm normalized name: SKF-96365 free base
DrugBank: SKF-96365 free base (DB17054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SKF 39393 (selective D-1 dopamine receptor agonist) at daily doses ranging from 3.2 to 32 mg/kg over treatment intervals of one to seven weeks.
Trial: 1153447
Drug: Ethanol self-administration
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol self-administration (8 drinks of ethanol, 89.12 g total)
Trial: 1153447
Drug: Orange juice
RxNorm normalized name: Orange juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orange juice self-administration (8 drinks of orange juice)
Trial: 30629160
Drug: Targeted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted therapy including mineralocorticoid receptor antagonists, statins, ACE inhibitors and/or receptor blockers, and cardiac rehabilitation.
Trial: 26173635
Drug: CRT-D treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRT-D treatment effect by LVEF interaction
Trial: 21520154
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of biomarkers PSMA, PSGR, and PCA3 detected by quantitative real-time PCR in post-PM urine sediment.
Trial: 18316236
Drug: Involuntary movements
RxNorm normalized name: docosahexaenoic acid / phosphatidylserine Oral Capsule [Senior Moment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Involuntary movements concurrent to speech
Trial: 18316236
Drug: Involuntary movements
RxNorm normalized name: docosahexaenoic acid / phosphatidylserine Oral Capsule [Senior Moment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Involuntary movements not concurrent to speech
Trial: 16702822
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil (20 mg/day)
Trial: 8127929
Drug: Moclobemide (300‐600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (300‐600 mg/d)
Trial: 8127929
Drug: Maprotiline (75‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline (75‐150 mg/d)
Trial: 28985255
Drug: Haloperidol 1
RxNorm normalized name: haloperidol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 1 mg orally twice-daily (maximum of 14 doses)
Trial: 23510450
Drug: 17 G/
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17 G/ 35 mm (standard) needle
Trial: 23510450
Drug: 20 G/
RxNorm normalized name: calcium gluconate 20 g/1000 mL-NaCl 0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 G/ 35 mm (thin) needle
Trial: 18602599
Drug: Targeted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted therapy (specific molecules not detailed)
Trial: 18602599
Drug: Cytotoxic chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytotoxic chemotherapy (not explicitly detailed)
Trial: 16736333
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy (intravenous for 2 days, followed by oral for 10 days)
Trial: 11775892
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg-20 mg, three times daily before labor, orally every 6 hours during labor)
Trial: 7036292
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with 5-fluorouracil (10 mg/kg/day) and BCNU (40 mg/m2/day) for 5 days, administered eight times in 6‐8 week intervals.
Trial: 7036292
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no chemotherapy).
Trial: 29705869
Drug: Suvorexant 100
RxNorm normalized name: Suvorexant
DrugBank: Suvorexant (DB09034)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suvorexant 100 mg
Trial: 27253658
Drug: Suvorexant (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suvorexant (all doses)
Trial: 26809022
Drug: Hybrid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid therapy (esomeprazole 20 mg and amoxicillin 1000 mg twice daily for 14 days with the addition of clarithromycin 500 mg and tinidazole 500 mg twice daily for the final 7 days)
Trial: 7299385
Drug: Caffeine 10
RxNorm normalized name: caffeine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 10 mg/kg
Trial: 21503180
Drug: Caffeine 15
RxNorm normalized name: caffeine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 15 mg/kg
Trial: 11026396
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g of glucose
Trial: 1587426
Drug: Oral erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral erythromycin (three times weekly for 1 month)
Trial: 27588932
Drug: 20 units
RxNorm normalized name: Omnipod GO 20 Units/Day Pods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 units of oxytocin diluted in 500 mL of lactated Ringer solution
Trial: 27588932
Drug: 30 units
RxNorm normalized name: Omnipod GO 30 Units/Day Pods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 units of oxytocin diluted in 500 mL of lactated Ringer solution
Trial: 27588932
Drug: 40 units
RxNorm normalized name: Omnipod GO 40 Units/Day Pods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 units of oxytocin diluted in 500 mL of lactated Ringer solution
Trial: 15451899
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (1.6 mg)
Trial: 15451899
Drug: Carrier solution
RxNorm normalized name: Valiant Barrier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carrier solution (control)